TABLE 2 from First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

crossref(2024)

引用 0|浏览0
暂无评分
摘要

Treatment-related treatment-emergent AEs by preferred term in ≥1 patient, any grade and grade 3

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要